Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
160 Health InternationalFRA:O66 -5.84%8 EBIT per Share is €-0.03 as of Dec. 2025. GuruFocus rates FRA:O66 with a GF Score™ of 8/100. The stock has 5 warning signs investors should review. Among 105 Medical Distribution companies, 160 Health International ranks worse than 50.48% on this metric.
160 Health International's EBIT per Share for the
six
months ended in Dec. 2025 was €-0.02.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.03.
During the past 3 years, the average EBIT per Share Growth Rate was 4.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for 160 Health International's EBIT per Share or its related term are showing as below:
FRA:O66'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 4 Med: 4 Max: 4
Current: 4
During the past 4 years, the highest 3-Year average EBIT per Share Growth Rate of 160 Health International was 4.00% per year. The lowest was 4.00% per year. And the median was 4.00% per year.
FRA:O66's 3-Year EBIT Growth Rate is ranked worse than 50.48% of 105
companies
in the Medical Distribution industry
Industry Median: 4
vs FRA:O66: 4.00
160 Health International (FRA:O66) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
160 Health International EBIT per Share Related Terms
160 Health International EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.03
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
160 Health International (FRA:O66) has a EBIT per Share of €-0.03 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on 160 Health International and its competitors. According to the industry distribution chart, 160 Health International ranks #53 out of 105 companies in the Medical Distribution industry, placing it in the top 50.5%.
Is 160 Health International's EBIT per Share too high?
160 Health International's current EBIT per Share is €-0.03. Based on the distribution chart, 160 Health International ranks #53 out of 105 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, 160 Health International has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does 160 Health International's EBIT per Share compare to MCK and COR?
According to the Medical Distribution industry distribution chart, 160 Health International ranks #53 out of 105 companies for EBIT per Share. This places 160 Health International in the lower half of its industry. The industry median EBIT per Share is 4.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Distribution company?
The median EBIT per Share among Medical Distribution companies is 4.00, based on 105 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on 160 Health International and its competitors. For the Medical Distribution industry, the median EBIT per Share is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 160 Health International's current EBIT per Share is €-0.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 160 Health International stock overvalued right now?
160 Health International (FRA:O66) has a current EBIT per Share of €-0.03. The current EBIT per Share is €-0.03. 160 Health International's overall GF Score™ is 8/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For 160 Health International (FRA:O66), the current EBIT per Share is €-0.03 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
160 Health International Ltd is an experienced pharmaceutical and healthcare product wholesaler and a digital healthcare integrated service provider in China. The company offers a wide assortment of high-quality pharmaceutical and healthcare products under both wholesale and retail models, to address a spectrum of customer needs. In addition, through its online healthcare and wellness service platform, Healthcare 160 Platform. It also provide digital healthcare and wellness solutions, empowering each Platform Participants, including business customers, medical and healthcare institutions, medical professionals, individual users, and third-party merchants, throughout the healthcare value chain and driving the digital transformation of China's healthcare and wellness industry.
8GF Score
Get the complete analysis for FRA:O66
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:O66 has been successfully added to your 
